Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 6
2005 3
2006 3
2007 4
2008 4
2009 1
2011 2
2012 7
2013 1
2014 2
2015 1
2016 2
2017 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
Lódi M, Bánhegyi V, Bódi B, Gyöngyösi A, Kovács Á, Árokszállási A, Hamdani N, Fagyas M, Édes I, Csanádi Z, Czuriga I, Kisvárday Z, Lekli I, Bai P, Tóth A, Papp Z, Czuriga D. Lódi M, et al. Among authors: czuriga i. J Transl Med. 2020 Dec 9;18(1):470. doi: 10.1186/s12967-020-02564-w. J Transl Med. 2020. PMID: 33298102 Free PMC article.
Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M, Priksz D, Fülöp GÁ, Bódi B, Gyöngyösi A, Nagy L, Kovács Á, Kertész AB, Kocsis J, Édes I, Csanádi Z, Czuriga I, Kisvárday Z, Juhász B, Lekli I, Bai P, Tóth A, Papp Z, Czuriga D. Lódi M, et al. Among authors: czuriga i. J Transl Med. 2019 Jul 19;17(1):229. doi: 10.1186/s12967-019-1978-0. J Transl Med. 2019. PMID: 31324258 Free PMC article.
[Ischaemic heart disease in cancer patients. Questions and problems].
Gulácsi-Bárdos P, Szokol M, Lódi M, Czuriga D, Czuriga I, Édes I, Nagy A, Sármán B. Gulácsi-Bárdos P, et al. Among authors: czuriga i. Orv Hetil. 2017 Oct;158(43):1691-1697. doi: 10.1556/650.2017.30897. Orv Hetil. 2017. PMID: 29135296 Review. Hungarian.
[Editor's Commentary].
Czuriga I. Czuriga I. Orv Hetil. 2016 Sep;157(38):1499. doi: 10.1556/650.2016.30573. Orv Hetil. 2016. PMID: 27640614 Hungarian. No abstract available.
Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
Mezei ZA, Bereczky Z, Katona É, Gindele R, Balogh E, Fiatal S, Balogh L, Czuriga I, Ádány R, Édes I, Muszbek L. Mezei ZA, et al. Among authors: czuriga i. Int J Mol Sci. 2015 Jan 6;16(1):1143-59. doi: 10.3390/ijms16011143. Int J Mol Sci. 2015. PMID: 25569091 Free PMC article.
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators. Lincoff AM, et al. JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321. JAMA. 2014. PMID: 24682069 Clinical Trial.
ST-segment elevation followed by progressive widening of the QRS complex.
Czuriga D, Barta J, Rácz I, Edes I, Györy F, Czuriga I, Csanádi Z. Czuriga D, et al. Among authors: czuriga i. JAMA Intern Med. 2013 Apr 8;173(7):490; discussion 491-2. doi: 10.1001/jamainternmed.2013.2959a. JAMA Intern Med. 2013. PMID: 23479024 No abstract available.
41 results